Mounjaro 7.5 mg pre-filled pen (tirzepatide)

Introduction

Mounjaro 7.5 mg (tirzepatide) is a prescription-only medicine supplied as a solution for injection in a pre-filled pen. It is used to support blood glucose control in adults with type 2 diabetes and may also be prescribed as part of a weight management plan under the supervision of a qualified healthcare professional. Supply is subject to a valid UK prescription and appropriate clinical screening.

Treatment Areas

Mounjaro may be prescribed for:

• Type 2 diabetes management

• Blood glucose control alongside diet and lifestyle measures

• Weight management (when clinically appropriate and prescribed)

Who is the right candidate?

Mounjaro may be suitable for adults who:

• Have type 2 diabetes

• Require additional glycaemic control

• Have been assessed and prescribed by a UK-registered prescriber

• Are able to use injectable medication safely

Ingredients

• Active ingredient: Tirzepatide

How to use

Administered as a once-weekly subcutaneous injection into the abdomen, thigh, or upper arm. Patients must follow prescriber instructions and refer to the patient information leaflet. Dose changes should only be made under medical supervision.

Benefits

• Improves blood glucose control

• Once-weekly dosing

• Supports individualised treatment plans

Storage

• Store refrigerated at 2°C to 8°C

• Do not freeze

• Keep in original packaging to protect from light

• May be stored below 30°C for a limited period (refer to leaflet)

• Keep out of sight and reach of children

Side Effects

Common side effects include:

• Nausea

• Vomiting

• Diarrhoea

• Reduced appetite

• Abdominal discomfort

Serious side effects may include pancreatitis or severe allergic reactions. Seek immediate medical attention if symptoms such as severe abdominal pain, persistent vomiting, or swelling occur. Refer to the patient information leaflet for full details.

Safety, Contraindications & Warnings

• Prescription-only medicine (POM)

• Not suitable for patients with a history of pancreatitis unless advised by a specialist

• Not recommended during pregnancy or breastfeeding

• Contraindicated in patients with hypersensitivity to tirzepatide or any excipients

• Use with caution in patients with severe gastrointestinal disease

• Not recommended in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

• Patients must provide accurate and complete medical information

• Do not share medication with others

Interactions & Additional Precautions

• May increase the risk of hypoglycaemia when used with insulin or sulfonylureas

• Patients should be cautious when driving or operating machinery if experiencing symptoms of low blood sugar

• Inform your prescriber of all current medications before starting treatment

Sharps Disposal

Used pens must be disposed of in an appropriate sharps container. Do not dispose of needles in household waste. Follow local guidelines or consult your pharmacist for safe disposal.

Clinical Responsibility

Medicine Porter dispenses medications in line with UK regulations. The prescribing clinician retains full responsibility for the clinical appropriateness of the prescription. Supply is subject to legal and clinical checks, and we reserve the right to refuse dispensing where necessary.

Order Information

Mounjaro 7.5 mg is supplied by Medicine Porter, a GPhC- and NHS England–regulated pharmacy. All medications are dispensed against a valid UK prescription and delivered securely and discreetly.